Issue of Equity
22 12월 2006 - 4:01PM
UK Regulatory
RNS Number:5093O
Cytomyx Holdings PLC
22 December 2006
Cytomyx Holdings plc (the 'Company')
The Company has today made application for 2,000,000 ordinary share to be
admitted to trading on AIM.
The ordinary shares were issued as a result of deferred consideration payable to
Aptus Pharmaceuticals and a payment in lieu of fees, but due to an
administrative error have not yet been admitted to trading on AIM. Admission is
expected to occur on 29 December 2006.
As a result of this admission the issued share capital of the Company has not
changed and remains at 63,608,256 ordinary shares.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEAKDKPABDDABB
Cytomyx (LSE:CYX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Cytomyx (LSE:CYX)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Cytomyx Hldgs (London Stock Exchange)의 실시간 뉴스: 최근 기사 0
More Cytomyx Hldgs Plc News Articles